Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Vopr Onkol ; 43(4): 448-53, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9381703

RESUMO

The investigation was concerned with the role of enzymouria in the assessment of nephrotoxic effects identified in 19 children with malignant solid tumors who received cisplatin polychemotherapy in a dose of 100 mg/sq.m or iphosphamide in a dose 9 g/sq.m. Chemotherapy application was followed by a persistent hyperenzymouria involving significantly higher levels of N-acetyl-beta-D-hexosaminidase, beta-glutamyl transferase and alanine aminopeptidase in the urine, as compared with basal indices. Iphosphamide treatment showed significantly higher levels of enzymouria than those in cisplatin-treated patients. Higher than normal creatinine and urea concentrations were recorded only in 2 out of 9 patients receiving iphosphamide. Enzymouria evaluation was shown to be an effective method of nephrotoxic diagnosis.


Assuntos
Antineoplásicos/efeitos adversos , Neoplasias/sangue , Neoplasias/urina , Insuficiência Renal/sangue , Insuficiência Renal/urina , Adolescente , Antineoplásicos Alquilantes/efeitos adversos , Criança , Pré-Escolar , Cisplatino/efeitos adversos , Creatinina/sangue , Creatinina/urina , Feminino , Humanos , Ifosfamida/efeitos adversos , Masculino , Neoplasias/tratamento farmacológico , Insuficiência Renal/induzido quimicamente , Ureia/sangue , Ureia/urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...